Skip to main content
Jonathan Krakoff, MD, Endocrinology, Phoenix, AZ

JonathanAKrakoffMD

Endocrinology Phoenix, AZ

Diabetes, Lipid Metabolism, Thyroid

Physician

Dr. Krakoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Krakoff's full profile

Already have an account?

  • Office

    4212 N 16th St
    Phoenix, AZ 85016
    Phone+1 602-200-5217
    Fax+1 602-200-5335

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
  • New York University School of Medicine
    New York University School of MedicineClass of 1989

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1999 - 2026
  • NY State Medical License
    NY State Medical License 1991 - 2001
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure  
    Jonathan Krakoff, MD, The Journal of Clinical Endocrinology and Metabolism
  • FGF21 Is a Hormonal Mediator of the Human “Thrifty” Metabolic Phenotype  
    Jonathan Krakoff, Clifton Bogardus, Karyne L Vinales, Diabetes Care

Authored Content

  • Exenatide Has a Pronounced Effect on Energy Intake but Not Energy Expenditure in Non-Diabetic Subjects with Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial☆March 2018

Press Mentions

  • Metabolites and Diabetes Remission After Weight Loss
    Metabolites and Diabetes Remission After Weight LossFebruary 24th, 2021
  • Long-Term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes MellitusFour-Year Results of the Look AHEAD Trial
    Long-Term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes MellitusFour-Year Results of the Look AHEAD TrialOctober 20th, 2016

Grant Support

  • Risk Factors And Etiology Of Obesity And Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Regulators Of Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Nutrient Absorption In Lean Versus Obese IndividualsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Neuronal Activity And Its Role In Adiposity And Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Mechanism And Effect Of Exenatide On Weight Loss: Randomized Controlled TrialNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Factors Which Predict Variance In Weight ChangeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • The Effect Of Salsalate On Insulin Action And SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • The Effect Of Salsalate On Insulin Action And SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2008
  • Neuronal Activity And Its Role In Adiposity And Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2008